Literature DB >> 16181185

A model for management of delirious postacute care patients.

Margaret A Bergmann1, Katharine M Murphy, Dan K Kiely, Richard N Jones, Edward R Marcantonio.   

Abstract

Although delirium has been shown to be a common, morbid, and costly problem for hospitalized older people, evidence has mounted that it may persist for weeks or months. Therefore, concern about delirium can no longer be confined to acute care. After an acute hospitalization, many older people are discharged to postacute care (PAC) facilities--rehabilitation hospitals and skilled nursing facilities. Although several models designed to prevent delirium in the hospital setting have been described, there have been few such efforts in the PAC setting. This article describes the development of a multifactorial delirium abatement program (DAP), a new model of care for older patients admitted to the postacute skilled nursing facility with delirium. The DAP is a nurse-led, unit-based intervention. The program consists of four modules based on best practices as defined by the peer-reviewed literature: standardized screening for symptoms and signs of delirium upon admission to the PAC unit, assessment and treatment of possible causes of and contributors to delirium, prevention and management of common delirium complications, and restoration of patient cognitive and self-care function. This article also presents the process of facility introduction, staff education on DAP content, and multidisciplinary outreach. Key strategies for DAP implementation are reviewed. Program adoption challenges and corresponding model refinements to enhance adherence and overall care quality are highlighted. Last, clinical adaptation of this research-derived program is discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16181185     DOI: 10.1111/j.1532-5415.2005.53519.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  11 in total

1.  Postoperative delirium: a 76-year-old woman with delirium following surgery.

Authors:  Edward R Marcantonio
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

2.  Randomized trial of a delirium abatement program for postacute skilled nursing facilities.

Authors:  Edward R Marcantonio; Margaret A Bergmann; Dan K Kiely; E John Orav; Richard N Jones
Journal:  J Am Geriatr Soc       Date:  2010-05-07       Impact factor: 5.562

3.  Delirium in the elderly: a review.

Authors:  Suzanne Wass; Penelope J Webster; Balakrishnan R Nair
Journal:  Oman Med J       Date:  2008-07

4.  Persistent delirium predicts greater mortality.

Authors:  Dan K Kiely; Edward R Marcantonio; Sharon K Inouye; Michele L Shaffer; Margaret A Bergmann; Frances M Yang; Michael A Fearing; Richard N Jones
Journal:  J Am Geriatr Soc       Date:  2009-01       Impact factor: 5.562

5.  Preliminary development of an ultrabrief two-item bedside test for delirium.

Authors:  Donna M Fick; Sharon K Inouye; Jamey Guess; Long H Ngo; Richard N Jones; Jane S Saczynski; Edward R Marcantonio
Journal:  J Hosp Med       Date:  2015-09-15       Impact factor: 2.960

Review 6.  Delirium in hospitalised older persons: review.

Authors:  B Alvarez Fernandez; F Formiga; R Gomez
Journal:  J Nutr Health Aging       Date:  2008-04       Impact factor: 4.075

Review 7.  Delirium in Hospitalized Older Adults.

Authors:  Edward R Marcantonio
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

8.  Prevalence of delirium on admission to postacute care is associated with a higher number of nursing home deficiencies.

Authors:  Richard N Jones; Dan K Kiely; Edward R Marcantonio
Journal:  J Am Med Dir Assoc       Date:  2010-03-06       Impact factor: 4.669

9.  The American Geriatrics Society/National Institute on Aging Bedside-to-Bench Conference: Research Agenda on Delirium in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-03-31       Impact factor: 5.562

10.  Alzheimer's disease and anesthesia.

Authors:  Marie-Amélie Papon; Robert A Whittington; Noura B El-Khoury; Emmanuel Planel
Journal:  Front Neurosci       Date:  2011-01-31       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.